A rapid drug test that reads non negative is not a finished result. It is a screening flag, and by design that flag has to be checked by a different, more precise method before anyone calls it a positive. That second step is lab confirmation testing, and it is the reason a non negative screen and a verified result rarely arrive on the same day. Understanding what actually happens between those two points helps collectors, employers, and donors set realistic expectations instead of guessing.
What a non negative screen actually means
Point of care and rapid cup screens use immunoassay chemistry. Antibodies in the device react to a drug or drug metabolite class at a set cutoff concentration, and if enough of that substance is present, the test line does not develop the way a negative would. Laboratories and regulators avoid the word "positive" at this stage on purpose. The result is presumptive. Immunoassay antibodies can cross react with structurally similar compounds, over the counter medications, or prescription drugs, so a non negative reading only means the specimen needs a more specific method to determine what is actually there.
Why every non negative screen goes to a confirmation lab
For any federally regulated drug test, a non negative screening result cannot be reported as positive on the strength of the screen alone. Under the Department of Transportation's testing rule, specimens that screen non negative must be sent to a certified laboratory for confirmatory testing using gas chromatography and mass spectrometry, or a comparably validated method, before a result is verified as positive, adulterated, or substituted. The initial and confirmation cutoff concentrations for each drug class are set out directly in 49 CFR 40.87. The same two step model, screen first, confirm second, underlies the Substance Abuse and Mental Health Services Administration's workplace testing program, and it is spelled out directly in SAMHSA's Mandatory Guidelines for Federal Workplace Drug Testing Programs, which require certified laboratories to run gas chromatography mass spectrometry or an equally validated confirmatory method before any non negative result is treated as final. Non federally regulated programs are not bound by these exact rules, but most reputable labs and collection sites follow the same logic because it is what stands up to scrutiny.
Screening versus confirmation testing
| Feature | Initial Screen (Immunoassay) | Confirmation Test (GC-MS / LC-MS-MS) |
|---|---|---|
| Where it happens | On site, at the collection point | At a certified laboratory |
| What it detects | A drug class, at a set cutoff | A specific drug or metabolite, at its own cutoff |
| Specificity | Lower, can cross react with other compounds | Very high, identifies the exact molecule |
| Result terminology | Negative or non negative | Positive, negative, adulterated, or substituted |
| Typical use | Fast presumptive screening of every specimen | Confirming only the specimens that screened non negative |
What GC-MS and LC-MS/MS confirmation actually involves
Gas chromatography mass spectrometry and liquid chromatography tandem mass spectrometry work on a different principle than the antibody reaction in a screening device. The specimen goes through extraction and, for GC-MS, a chemical preparation step that makes the target compound suitable for the instrument. It is then separated by chromatography and passed through a mass spectrometer, which breaks the molecule into a fragmentation pattern that is effectively unique to that compound. The lab compares that pattern against a known reference standard for the specific drug in question. This is what makes confirmation testing legally and scientifically defensible in a way a screen alone is not, and it is also why confirmation involves more instrument time, more technician handling, and more quality control checkpoints than a screen that reads in minutes.
The Medical Review Officer review step
For DOT regulated tests and many other regulated programs, a laboratory confirmed positive result is still not the end of the process. It goes to a Medical Review Officer, a licensed physician trained in substance abuse testing, who reviews the laboratory data and gives the donor an opportunity to provide a legitimate medical explanation, such as a valid prescription, before the result is verified. The MRO's role and the interview requirement are laid out in 49 CFR 40.129. Only after that review is complete does the result become a verified positive that gets reported to the employer. Our Medical Review Officer process guide walks through what that conversation covers and what donors should have ready. If the specimen is not part of a regulated MRO program, some employers and clinics handle result review internally, but the underlying idea, giving the donor a chance to explain a confirmed result before it is treated as final, remains a sound practice.
What actually determines how long the process takes
Federal drug testing regulations specify what steps have to happen and in what order, but they do not set a fixed clock for how many hours or days the whole sequence must take. That is left to the certified laboratory and the specific testing program. A few factors that genuinely affect timing:
- Specimen transport. A confirmation lab cannot start until the specimen physically arrives, so courier and shipping logistics matter as much as lab throughput.
- Laboratory volume. Confirmation testing is batched and instrument time is shared across many specimens, so a lab running high volume on a given day processes differently than one running light volume.
- Whether the MRO can reach the donor. A confirmed positive result cannot be verified until the MRO interview happens, and that step depends on the donor being reachable.
- Split specimen retesting. If a donor requests that the split specimen be tested at a second certified lab, that adds a separate confirmation run on top of the first.
Because of this, any specific turnaround number quoted for a given test is a statement about that laboratory's own operations, not a federal guarantee. Programs that need predictable timing should ask their laboratory directly what its typical process looks like rather than assuming a fixed standard applies everywhere.
What employers and collectors should do while confirmation is pending
A non negative screen is a reason to follow the program's standard procedure, not a reason to take action against an employee. Chain of custody documentation should stay intact and untouched while the specimen is in transit and under review, since a court defensible result depends on that paper trail as much as on the lab work itself. For on site screening, using reliable, well documented rapid test devices reduces false non negatives and false non negatives alike, which is part of why programs stock consistent, quality controlled screening supplies such as those in our drug testing collection rather than mixing device lots or brands mid program. For a closer look at exactly what happens to a specimen inside the confirmation lab, see our companion article on what lab confirmation does after a non negative screen.
Frequently asked questions
Does a non negative screen mean someone failed a drug test?
No. A non negative screen means the initial immunoassay test detected enough of a substance to require confirmation. It is a presumptive result, not a final one, and a meaningful share of non negative screens do not confirm positive once tested with a more specific method.
How is a confirmation test different from a screening test?
A screening test uses antibodies to flag a drug class at a set cutoff and can react to structurally similar compounds. A confirmation test, using gas chromatography mass spectrometry or liquid chromatography tandem mass spectrometry, identifies the specific drug molecule itself and is run at a certified laboratory rather than on site.
Who reviews a confirmed positive result before it becomes official?
For DOT regulated and many other regulated testing programs, a Medical Review Officer, a licensed physician with specific training in this role, reviews the laboratory's confirmation data and interviews the donor for a legitimate medical explanation before the result is verified as positive.
Can an employee explain a confirmed positive result?
Yes. The Medical Review Officer review exists specifically to give the donor an opportunity to provide documentation, such as a valid prescription, that could explain a confirmed result before it is reported to the employer as verified.
What happens if the confirmation test comes back negative?
If the confirmation test does not detect the drug at the confirmation cutoff, the result is reported as negative. This can happen even after a non negative screen, since the screen is a less specific method and confirmation testing is designed to catch and correct that difference.
Related reading
This article is general information about how laboratory confirmation testing works and is not legal or medical advice. Employers, collectors, and testing programs should consult their own counsel, Medical Review Officer, or certified laboratory for guidance specific to their program and jurisdiction.
